 Connection
Krista Eschbach to Status Epilepticus
This is a "connection" page, showing publications Krista Eschbach has written about Status Epilepticus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.143 |
|
|
|
-
Shrestha A, Silveira LJ, Thomas D, Leech J, Lai YC, Riviello JJ, Muscal E, Soden J, Eschbach K. Gastrointestinal symptoms are common in patients with new-onset refractory status epilepticus (NORSE). Neurol Sci. 2025 Oct; 46(10):5305-5314.
Score: 0.858
-
Eschbach K, Reedy J, Gofton T, Gopaul M, Farias-Moeller R, Kellogg M, Knupp K, Hirsch LJ, Wong N, Dorsey Holliman B. Navigating life after New-onset refractory status epilepticus (NORSE) and Febrile infection-related epilepsy syndrome (FIRES): Insights from caregiver and patient interviews. Epilepsy Behav. 2025 Feb; 163:110236.
Score: 0.821
-
Meletti S, Hanin A, Giovannini G, Bedin R, Burani M, Taruffi L, Orlandi N, Urbano T, D'Achille F, Malerba M, Basha MM, Eschbach K, Foreman B, Farias-Moeller R, Gaspard N, Gerard EE, Gofton T, Gopaul MT, Haider HA, Hantus ST, Herman S, Kang P, Day GS, Kandula P, Steriade C, Struck AF, Taraschenko O, Wainwright M, Yoo JY, Zhou DJ, Lattanzi S, Navarro V, Hirsch LJ. Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus. JAMA Neurol. 2026 Jun 01; 83(6):563-572.
Score: 0.226
-
Hanin A, Marois C, Guillemaud M, Chavez M, Cosme L, Hayatou Z, Besnard A, Goudard G, Masson V, Cousyn L, Cheval M, Denis JA, Alkouri R, Lamari F, Bisulli F, Eschbach K, Farias-Moeller R, Gaspard N, Gerard EE, Giovannini G, Gofton T, Gopaul MT, Kellogg M, Meletti S, Muccioli L, Pasini E, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Wong N, Bonnefont-Rousselot D, Demeret S, Hirsch LJ, Navarro V. Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus. Epilepsia. 2026 May; 67(5):2326-2346.
Score: 0.222
-
Gruen MD, Gopaul MT, Jimenez AD, Batra A, Blank LJ, Damien C, Day GS, Eschbach K, Gerard EE, Gofton TE, Hantus ST, Jette N, Jongeling A, Kang P, Kazazian K, Kellogg M, Kim M, Madani B, Morales M, Punia V, Steriade C, Struck A, Taraschenko O, Torcida N, Wainwright MS, Yoo JY, Gaspard N, Wong N, Hirsch LJ, Hanin A. Quality of life over time after new onset refractory status epilepticus. Epilepsia. 2026 01; 67(1):328-340.
Score: 0.215
-
Guillemaud M, Hanin A, Riviello JJ, Chavez M, Batra A, Berry M, Bisulli F, Castillo-Pinto C, Cobos-Hernandez C, Demeret S, Eschbach K, Farias-Moeller R, Fields M, Gaspard N, Gerard EE, Gofton TE, Gopaul MT, Gruen MD, Jimenez AD, Kazazian K, Kim M, Mansour M, Marcuse L, Marois C, Morales M, Muccioli L, Pasini E, Pham MM, Rosas SP, Struck AF, Torcida N, Wainwright MS, Yoo JY, Muscal E, Navarro V, Hirsch LJ, Lai Y. Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study. Epilepsia. 2025 Dec; 66(12):4780-4794.
Score: 0.215
-
Guillemaud M, Chavez M, Kobeissy F, Vezzani A, Jimenez AD, Basha MM, Batra A, Demeret S, Eka O, Eschbach K, Foreman B, Gaspard N, Gerard EE, Gofton TE, Haider HA, Hantus ST, Howe CL, Jongeling A, Kalkach-Aparicio M, Kandula P, Kazazian K, Kim M, Lai YC, Marois C, Mellor A, Mohamed W, Morales M, Pimentel CM, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Torcida Sedano N, Wainwright MS, Yoo JY, Wang KKW, Navarro V, Hirsch LJ, Hanin A. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling. Neurol Neuroimmunol Neuroinflamm. 2025 Jul; 12(4):e200403.
Score: 0.210
-
Espino PH, Eschbach K, Blank LJ, Cervenka MC, Muscal E, Farias-Moeller R, Gilmore EJ, Gopaul MT, Haider HA, Hanin A, Hirsch LJ, Kellogg MA, Kluger G, Lee ST, Melendez-Zaidi AE, Navarro V, Oliger AC, Pasini E, Reuner G, Sharpe CM, Sheikh ZB, Steigleder L, Steriade C, Stredny CM, Strzelczyk A, Taraschenko O, van Baalen A, Vinette SA, Wickström R, Wong NW, Yoo J, Gofton TE. New onset refractory status epilepticus: Long-term outcomes beyond seizures. Epilepsia. 2025 Apr; 66(4):988-1005.
Score: 0.206
-
Kazazian K, Gaspard N, Hirsch LJ, Kellogg M, Hocker SE, Wong N, Farias-Moeller R, Eschbach K, Gofton TE. Age-associated differences in FIRES: Characterizing prodromal presentation and long-term outcomes via the web-based NORSE/FIRES Family Registry. Epilepsia. 2025 Mar; 66(3):e35-e40.
Score: 0.206
-
Kazazian K, Gaspard N, Hirsch LJ, Kellogg M, Hocker SE, Wong N, Farias-Moeller R, Eschbach K, Gofton TE. Communication trends over time in new-onset refractory status epilepticus (NORSE): Interim analysis from the NORSE/FIRES Family Registry. Epilepsy Behav. 2024 Nov; 160:110023.
Score: 0.201
-
Hanin A, Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel CM, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Wainwright MS, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ. Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis. Epilepsia. 2024 Aug; 65(8):e148-e155.
Score: 0.197
-
Jimenez AD, Gopaul M, Asbell H, Aydemir S, Basha MM, Batra A, Damien C, Day GS, Eka O, Eschbach K, Fatima S, Fields MC, Foreman B, Gerard EE, Gofton TE, Haider HA, Hantus ST, Hocker S, Jongeling A, Kalkach Aparicio M, Kandula P, Kang P, Kazazian K, Kellogg MA, Kim M, Lee JW, Marcuse LV, McGraw CM, Mohamed W, Orozco J, Pimentel C, Punia V, Ramirez AM, Steriade C, Struck AF, Taraschenko O, Treister AK, Yoo JY, Zafar S, Zhou DJ, Zutshi D, Gaspard N, Hirsch LJ, Hanin A. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis. Epilepsia. 2024 Jun; 65(6):e87-e96.
Score: 0.195
-
Hanin A, Eschbach K, Gofton TE, Gopaul M, Howe CL, Lai YC, Koh S, Shen H, Hirsch LJ. New onset refractory status epilepticus: Summary of the NORSE Institute roundtable during the 2023 American Epilepsy Society meeting, Orlando, Florida. Epilepsia. 2024 Apr; 65(4):1145-1146.
Score: 0.194
-
Eschbach K, Knupp KG. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May; 12(5):379-388.
Score: 0.138
-
Koh S, Wirrell E, Vezzani A, Nabbout R, Muscal E, Kaliakatsos M, Wickström R, Riviello JJ, Brunklaus A, Payne E, Valentin A, Wells E, Carpenter JL, Lee K, Lai YC, Eschbach K, Press CA, Gorman M, Stredny CM, Roche W, Mangum T. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open. 2021 03; 6(1):62-72.
Score: 0.039
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|